Open Government Portal

Found 10 records similar to WTO-member countries eligible to import under Canada's Access to Medicines Regime

Federal

It presents WTO-Member Countries and Non-WTO Member Countries Eligible to Import Under the Regime.

Last Updated: Sep. 17, 2020
Date Published: Mar. 17, 2017
Organization: Health Canada
Formats: HTML
Keywords:  Canada's Access to Medicines Regime, WTO-member countries, non-WTO member countries, countries eligible to import under the Regime.
Federal

It presents the list Least-Developed Countries Eligible to Import Under the Regime.

Last Updated: Sep. 17, 2020
Date Published: Mar. 17, 2017
Organization: Health Canada
Formats: HTML
Keywords:  Canada's Access to Medicines Regime, Least-developed countries, countries eligible to import under the Regime.
Federal

In August 2003, negotiations among World Trade Organization (WTO) members resulted in a landmark decision to waive two licensing provisions of the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) that appeared to prevent the export of generic drugs and medical devices to developing countries faced with public health problems.

Last Updated: Sep. 17, 2020
Date Published: Mar. 28, 2017
Organization: Health Canada
Formats: HTML
Keywords:  Canada's Access to Medicines Regime, World Trade Organization, waive licensing provisions, WTO Agreement, Intellectual Property Rights, developing and least-developed countries, import high-quality drugs and medical devices
Federal

Countries with insufficient or no manufacturing capacity in the pharmaceutical sector can benefit from participating in Canada's Access to Medicines Regime. Under the Regime, eligible countries can import less expensive, generic versions of patented products manufactured in Canada.

Last Updated: Sep. 17, 2020
Date Published: Mar. 29, 2017
Organization: Health Canada
Formats: HTML
Keywords:  Country access, Canada's Access to Medicines Regime, insufficient or no manufacturing capacity in the pharmaceutical sector, import a lower cost drug and medical devices.
Federal

To participate in the Regime, an eligible importing country must declare that it has insufficient or no pharmaceutical manufacturing capacity in relation to the specific product it is requesting. It is up to each country to determine for itself the level of its manufacturing capacity.

Last Updated: Sep. 17, 2020
Date Published: Mar. 29, 2017
Organization: Health Canada
Formats: HTML
Keywords:  Canada's Access to Medicines Regime, manufacturing capacity, eligible importing country, insufficient or no pharmaceutical manufacturing capacity.
Federal

To participate in the Regime, a pharmaceutical company must enter into a sales agreement with an eligible importing country for the purchase of a specified amount of an eligible product listed on Schedule 1. A pharmaceutical company must also submit an application for authorization to Canada's Commissioner of Patents. Once the authorization or compulsory licence is issued, there are additional terms and conditions that the company must meet and maintain.

Last Updated: Sep. 17, 2020
Date Published: Mar. 29, 2017
Organization: Health Canada
Formats: HTML
Keywords:  Company requirements under Canada's Access to Medicines Regime, sales agreement, compulsory licence, eligible importing country, eligible product, application for authorization to Canada's Commissioner of Patents.
Federal

Within 30 days of the end of the two-year period of the original compulsory licence, a pharmaceutical company may apply to have it renewed. A renewal will only be granted if the full shipment of the original authorization has not yet been shipped. Only one renewal is allowed for each original application for a total of four years for each compulsory licence.

Last Updated: Sep. 17, 2020
Date Published: Mar. 29, 2017
Organization: Health Canada
Formats: HTML
Keywords:  Canada's Access to Medicines Regime, renewal of licence, original compulsory licence, pharmaceutical company.
Federal

Instructions for complying with the Requirements of Canada's Access to Medicines Regime specify how to notify the World Trade Organization or the Government of Canada, and how to request the addition of a particular drug or medical device to the list of eligible products.

Last Updated: Sep. 17, 2020
Date Published: Mar. 29, 2017
Organization: Health Canada
Formats: HTML
Keywords:  Canada's Access to Medicines Regime, comply with procedures, requirements of Canada's Access to Medicines Regime, addition of a particular drug or medical device to the list of eligible products.
Federal

The company must submit the application package to the Commissioner of Patents at the Canadian Intellectual Property Office (CIPO).

Last Updated: Sep. 17, 2020
Date Published: Apr. 28, 2017
Organization: Health Canada
Formats: HTML
Keywords:  Canada's Access to Medicines Regime, submit the application package, the Commissioner of Patents at the Canadian Intellectual Property Office.
Federal

The patent holder may seek an order from the Federal Court of Canada to terminate a compulsory licence, if the patent holder can establish that any information in the application by the licence holder is inaccurate or that the licence holder has failed

Last Updated: Sep. 17, 2020
Date Published: Mar. 29, 2017
Organization: Health Canada
Formats: HTML
Keywords:  Canada's Access to Medicines Regime, termination of authorization, terminate a compulsory licence, patent holder, Federal Court of Canada.
Date modified: